Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00748254 · ClinicalTrials.gov registry record
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
A clinical trial of Arthritis, Rheumatoid, sponsored by University of Michigan.
- Recruiting
- Registry status
- 113
- Enrollment target
- 1
- Study location
NCT00748254 is a study of Arthritis, Rheumatoid that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 113 participants, below the 637-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00748254, a study of Arthritis, Rheumatoid, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- 113 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this feasibility study is to determine if a new emerging technology called photoacoustic tomography (PAT) can be adapted for use in humans for the detection of chronic rheumatoid arthritis.
Conditions Studied
Interventions
- PROCEDURE Laser Based Photoacoustic Tomography, MRI, Ultrasound
- PROCEDURE laser based photoacoustic tomography, MRI, ultrasound
Study Locations (1)
Michigan
- Universtity of Michigan Health System - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2011-12-01 |
| Est. Completion | 2027-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00748254
The ClinicalTrials.gov registry entry for NCT00748254 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 637-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (82% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Arthritis, Rheumatoid appearing as the primary indexed condition, and to 2 interventions - of which Laser Based Photoacoustic Tomography, MRI, Ultrasound is the first listed.
NCT00748254 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT00748254 about?
NCT00748254 is a clinical study titled "Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis". The purpose of this feasibility study is to determine if a new emerging technology called photoacoustic tomography (PAT) can be adapted for use in humans for the detection of chronic rheumatoid arthritis.
What is the current status of trial NCT00748254?
This trial is currently recruiting. The enrollment target is 113 participants. The study started on 2011-12-01. Estimated completion is 2027-01.
What conditions does trial NCT00748254 study?
This clinical trial studies the following conditions: Arthritis, Rheumatoid.
What interventions are being tested in trial NCT00748254?
The interventions under investigation include: Laser Based Photoacoustic Tomography, MRI, Ultrasound (PROCEDURE), laser based photoacoustic tomography, MRI, ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT00748254?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00748254 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthritis, Rheumatoid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Chronic Pain in Rheumatoid Arthritis
RECRUITING
-
R-2487 in Patients With Rheumatoid Arthritis
RECRUITING · Phase 1
-
IMPACT - AndHealth Autoimmune Research Registry
RECRUITING
-
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)
RECRUITING · Phase 2
-
INFINITY™ With ADAPTIS™ Technology Study
ACTIVE NOT RECRUITING
-
Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.